#phenobarbital

teen hannibal ficlets by emungere What it says on the tin: a collection of ficlets about teen Hannibal and Will. This is the original prompt: AU where Hannibal never meets Lady Murasaki and is somehow found by Will Graham and Will raises him instead. As Hannibal gets older he becomes obsessed with Will and so Teen Hannibal tries to seduce Guardian Will who is just like oh god someone save me. It's pretty accurate. - The underage warning is for kissing and discussions only, but they do have sex eventually, when Hannibal's much older.

Totally Functional by Phenobarbital Will Graham was a relatively happy and overall average Alpha, which, as Alpha’s went, was not a bad thing. What he wasn’t…was straight.

Six Minutes In Heaven by mokuyoubi Beverly has somehow roped Hannibal into joining in on drinking games, and she has one clear objective in mind for him and Will...

The God of Appetite by mokuyoubi Professor William Graham of Georgetown University is travelling through Europe on behalf of Doctor Jack Crawford, who hopes to find proof of the existence of the killer who has been preying on young men and women for nearly a century. Though others would attribute the deaths to multiple killers and wild animals, Crawford insists that they are after one creature--a vampire. Will isn't sure what to believe, but with his unique gift of empathy, he's gained some insight into the mind of the killer...and what he's seen unsettles him greatly. With the help of Hannibal Lecter, a doctor in a small village near the epicentre of the attacks, Will hopes to find the responsible party.

Seizures are scary as an owner, an even as a veterinarian. Understanding the terminology, differentials, and treatment options will help you inform your clients and work toward a solution for their pet.

Epilepsy is classified into three categories: genetic (idiopathic), structural-metabolic, and epilepsy of unknown cause.

Genetic epilepsy: “The epilepsy is genetic when the result of a known or presumed genetic defect; seizures are the core symptom of the disorder” - ILAE Commission Report, Epilepsia 2010. Breeds include beagles, golden retrievers, german shepherds, vizlas, and many more.

Structural-Metabolic: The result of a structural (glioma, malformation, etc.) or metabolic (mitochondrial disease, storage disease, etc.) abnormality in the brain. Please note that metabolic refers to primary metabolic cerebral disease; seizures resulting from hypoglycemia or hypocalcemia are not epileptic as once the abnormality is corrected, the seizures should cease. Hepatic encephalopathy seizures are considered structural epilepsy.

Epilepsy of unknown cause: Seizures that are likely caused by a structural or metabolic abnormality but no cause has been identified.

i did not know real fluff until i binge-read 82k words of @phenobarbitalfiction writing Will’s sexuality crisis through Hannibal’s perspective.

Phenobarbital, a prolonged-acting barbiturate, has historically played a crucial role in addressing symptoms related to alcohol withdrawal. Its sedative properties make it a valuable tool for mitigating potential harm arising from sudden cessation of alcohol consumption. Over time, medical practices and treatment methods have evolved. This exploration delves into the use of phenobarbital for alcohol withdrawal. We examine the nuanced aspects of incorporating phenobarbital into a comprehensive strategy for managing alcohol withdrawal, including considerations of dosage and structured protocols.

Understanding the Prescribed Uses of Phenobarbital

Phenobarbital, a type of barbiturate, is commonly prescribed for various neurological disorders. Its primary application lies in serving as an anticonvulsant to help individuals with epilepsy regulate and prevent seizures effectively. By modifying the production of specific neurotransmitters in the brain, phenobarbital balances electrical activity, reducing the likelihood of abnormal neuronal firing. While it plays a crucial role in epilepsy treatment, its use has extended to addressing certain sleep disorders, providing temporary relief for insomnia due to its calming effects. However, its utilization for sleep issues is reserved for specific cases where other, less habit-forming options have proven ineffective.

The Role of Phenobarbital in Alcoholism Treatment

While not designed to cure alcoholism, phenobarbital has been employed in the past to alleviate symptoms associated with alcohol withdrawal. Its calming and sedative properties can help mitigate the negative effects of abruptly discontinuing alcohol consumption. Nevertheless, advancements in medical approaches to alcohol withdrawal now favor alternative medications with lower potential for side effects and dependence.

Dosage Considerations for Phenobarbital in Alcohol Withdrawal

When used for alcohol withdrawal, phenobarbital is administered in carefully measured doses under medical supervision. Dosage adjustments may be made based on factors such as the severity of withdrawal symptoms, the patient's age, weight, and overall health. A loading dose is typically given initially to establish a consistent medication level, followed by closely monitored maintenance doses. Customizing phenobarbital dosage is crucial to prevent issues like oversedation or undertreatment during the withdrawal process.

Structured Phenobarbital Protocol for Alcohol Withdrawal

The global Phenobarbital Market is estimated to be valued at US$ 1.58 billion in 2023 and is expected to exhibit a CAGR of 5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Phenobarbital is a barbiturate medication primarily used to treat seizures in epilepsy patients. It acts as a sedative and anticonvulsant, helping to control the abnormal electrical activity in the brain that causes seizures. The market for phenobarbital is driven by the increasing prevalence of epilepsy, a neurological disorder affecting millions of people worldwide. As the demand for effective epilepsy treatment continues to rise, the use of phenobarbital is expected to grow significantly.

Market Key Trends:

One key trend in the phenobarbital market is the growing preference for generic drugs. The increasing cost of branded medications and the expiration of patents have led to a surge in the adoption of generic alternatives, including phenobarbital. Generic drugs offer the same therapeutic benefits at a lower price, making them more accessible to a larger population. For instance, companies like Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., and Mylan N.V. are prominent players in the generic phenobarbital market.

PEST Analysis:

Political:

The political landscape plays a crucial role in the availability and pricing of phenobarbital. Governments regulate drug pricing and approval processes, which can impact the market dynamics.

Economic:

The economic factors affecting the phenobarbital market include healthcare expenditure, insurance coverage, and affordability of medications for patients.

Social:

The increasing awareness about epilepsy and its treatment options among healthcare professionals and patients is driving the demand for phenobarbital.

Technological:

Advancements in formulation techniques and drug delivery systems are improving the efficacy and safety profile of phenobarbital, contributing to the market growth.

Key Takeaways:

1. The global phenobarbital market is expected to witness high growth, exhibiting a CAGR of 5% over the forecast period. This can be attributed to the increasing prevalence of epilepsy and the growing demand for effective seizure control medications.

2. Regionally, North America is expected to dominate the phenobarbital market due to a well-established healthcare infrastructure and high adoption rate of antiepileptic drugs.

3. Key players operating in the global phenobarbital market include Sanofi, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, Zydus Cadila, Lannett Company, Inc., Strides Pharma Science Limited, Cipla Ltd., Lupin Limited, Aurobindo Pharma Limited, Torrent Pharmaceuticals Ltd., and Dr. Reddy's Laboratories Ltd.